Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment

Background: Immune checkpoint inhibitor (ICI)–associated myocarditis is an uncommon and potentially fatal immune-related adverse event (irAE). Although corticosteroids are recommended as the first-line treatment by current guidelines, patients still have variable responses to it, and the guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cong, Lin, Jinyi, Wang, Yan, Hsi, David H., Chen, Jiahui, Liu, Tianshu, Zhou, Yuhong, Ren, Zhenggang, Zeng, Zhaochong, Cheng, Leilei, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685452/
https://www.ncbi.nlm.nih.gov/pubmed/34938185
http://dx.doi.org/10.3389/fphar.2021.770631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685452/
https://www.ncbi.nlm.nih.gov/pubmed/34938185
http://dx.doi.org/10.3389/fphar.2021.770631

Ejemplares similares